Digitalisation in the pharmaceutical industry is steadily becoming more important, exploiting the integration of advanced digital technologies to streamline and accelerate the production of biopharmaceuticals. A crucial aspect of this digital transformation is the meticulous collection and analysis of large amounts of data throughout the development and manufacturing processes. In this context, employing solid probes and sensors is key to gathering real-time data on critical parameters. This precise data collection enables better monitoring and control of bioprocesses and combined with machine learning and data-driven tools, leads to improved process development timelines and consistency, and product quality. Ultimately, digitalisation can significantly accelerate innovation, reduce costs, and ensure high compliance in the pharmaceutical industry.